Document is current

Article History

Received: 17 October 2022

Accepted: 2 November 2023

First Online: 17 November 2023

Declarations

:

: This study was reviewed and approved by the Institutional Review Board at the Medical University of South Carolina as exempt, as it was deemed as involving research activities that <i>presented no risk or less than minimal risk as defined by the federal regulations, 46.104.”</i> Since this study involved review of existing records, no patient participant was involved. Thus, it was not possible to obtain patient informed consent, and the IRB at the Medical University of South Carolina granted the request for a waiver, with the following statement: “<i>The Institutional Review Board for Human Research (IRB) at the Medical University of South Carolina also recommends approval of the investigator's request for a HIPAA Waiver of Authorization, as it appears that the criteria of the Privacy Rule have been satisfied. The HIPAA Waiver of Authorization was reviewed under exempt review procedures.”</i>All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare no competing interests.